The India BioEconomy Report, released by the Department of Biotechnology, says there is ample opportunity for this sector to ...

India’s first indigenous dengue vaccine, DengiAll, is currently in Phase 3 trials involving over 10,335 participants across ...

Among key findings, 2022 emerged as a standout year with a record USD 749 million invested—nearly 40% of the five-year total. However, funding saw a dip to USD 269 million in 2024, indicating a ...

India, co-leading the Mission Integrated Biorefinery alongside the Netherlands under Mission Innovation 2.0, showcased its ...

See, nuclear energy is inevitable, because if you look at the energy mix, which is required for net zero carbon by 2070, ...

Hyderabad (Telangana) [India], March 20 (ANI): Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of ...

HYDERABAD, March 20 (Reuters) - Indian vaccine maker Bharat Biotech said on Thursday it had invested $75 million in its first cell and gene therapy (CGT) facility in the southern Indian state of ...

India and Germany reaffirmed their commitment to strengthening bilateral cooperation in science, technology and innovation ...

President Trump spares tariffs on pharmaceuticals, but says that he is worried about supply issues given most drugs in the ...

Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of India's only vertically integrated, purpose ...